Ewha Womans University

School of the Art Institute of Chicago Announces Jiseon Lee Isbara as Next President

Retrieved on: 
Friday, February 16, 2024
School, Mental health, Education, Growth, Retirement, Colorado State University, Art, Empathy, Learning, Life, SAIC, Faculty, University, Art Institute, Human, Creativity, OCAC, Trustee, Teaching, Ewha Womans University, Environment, Student, Management

CHICAGO, Feb. 16, 2024 /PRNewswire/ -- The School of the Art Institute of Chicago (SAIC), a leader in art and design education, today announced Jiseon Lee Isbara as the School's next president, completing a successful national search. Jiseon, who currently serves as the provost of Otis College of Art and Design in Los Angeles, will step into the role that will be vacated by Elissa Tenny upon her retirement.

Key Points: 
  • CHICAGO, Feb. 16, 2024 /PRNewswire/ -- The School of the Art Institute of Chicago (SAIC), a leader in art and design education, today announced Jiseon Lee Isbara as the School's next president, completing a successful national search.
  • Jiseon, the second woman to serve as president in SAIC's 158-year history, comes to the School with extensive experience in higher education and the arts.
  • "SAIC is composed of a community of diverse people, philosophies, pedagogies, and goals, and I am honored to serve as the School's next president," said Jiseon.
  • "I am so thrilled that Jiseon will serve as the next president of the School of the Art Institute of Chicago," said Board of Trustees Chair Denise B. Gardner.

Korea University and Ewha Womans University Researchers Highlight Advancements in Biomedical Research with Enzyme-activated Fluorescent Probes

Retrieved on: 
Wednesday, November 15, 2023
Medicine, Research, Energy, Tissue, Enzyme, Neoplasm, Biomedical Research, Cell death, Food safety, Cancer, Diagnosis, The central science, Water, Biomarker, Diabetes, Cell, Ewha Womans University, Fluorescence, Microscope, Medical imaging

SEOUL, South Korea, Nov. 15, 2023 /PRNewswire/ -- Enzymes, essential for normal cellular and physiological functions, are implicated in various diseases like cancer and diabetes due to their abnormal activity. Therefore, tracking enzyme activity is a valuable strategy for the diagnosis and monitoring of diseases. Conventional imaging techniques are limited by the need for contrast agents, low sensitivity, and spatio-temporal resolution. To overcome these limitations, researchers are increasingly investigating fluorescent probes for non-invasive and real-time visualization of enzyme dynamics and corresponding disease status.

Key Points: 
  • To overcome these limitations, researchers are increasingly investigating fluorescent probes for non-invasive and real-time visualization of enzyme dynamics and corresponding disease status.
  • In a new review article, researchers from Korea have summarized the latest advancements in the development of enzyme-activated near-infrared (NIR) fluorescent probes and their diverse applications in biomedical research and medicine.
  • Enzyme-activated fluorescent probes offer high specificity and sensitivity, excellent biocompatibility, ease of use, and tunable properties, making them valuable assets in biomedical research and healthcare.
  • This review enhances our understanding of fluorescent probes and lays the foundation for future research that can expand their applications.

Korea Ginseng Corp. Makes Waves in the Global Ginseng Raw Ingredient Market, Introducing JungKwanJang G1899 at SupplySide West 2023

Retrieved on: 
Friday, October 27, 2023
Science, Exhibition, Food, History, Research, Ewha Womans University, European cuisine, KGC, Growth, Immunity, System, Dietary supplement

US (KGCUS) is fresh off its first ever appearance at North America's largest food and health food raw material exhibition.

Key Points: 
  • US (KGCUS) is fresh off its first ever appearance at North America's largest food and health food raw material exhibition.
  • Held in Las Vegas, SupplySide West is the marquee event in the health food raw material space, featuring 18,000+ visitors and 1,400+ companies from around the world.
  • To demonstrate the unique excellence of its Korean red ginseng in the world's largest health supplement market – the United States – KGC's booth showcased both the breadth and the variety of its standardized Korean red ginseng raw ingredient brand, G1899 .
  • "We will continue to promote the excellence of red ginseng as a distinctive ginseng raw ingredient and consistently create opportunities to showcase JungKwanKang's products worldwide."

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Retrieved on: 
Friday, November 25, 2022
FDA, Clinical trial, Docetaxel, Pancreas, Survival, Pancreatic cancer, Chemistry, Ewha Womans University, Cytotoxicity, Animal, Toxicity, Conference, Multimedia, Cancer, Human, Neoplasm, CMC, Safety, Pharmacy, Research, NOAEL, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disulfiram-like drug, No-observed-adverse-effect level, Yale School of Medicine, GBC, Diagnosis, Food, Patient, Medical imaging, Pharmaceutical industry

This chemotherapy is a patient-centered treatment that focuses on controlling toxicity of anticancer drug.

Key Points: 
  • This chemotherapy is a patient-centered treatment that focuses on controlling toxicity of anticancer drug.
  • Polytaxel is loaded with docetaxel as its active pharmaceutical ingredient, which is known as one of the major chemotherapy drugs.
  • He said, "Based on the very low toxicity of Polytaxel, a completely new standard treatment to enable pain-free anticancer treatment has emerged."
  • For the two-dose group, it will take 8 days to complete administration, and 15 days for the three-dose group.

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Retrieved on: 
Friday, November 25, 2022
FDA, Clinical trial, Docetaxel, Pancreas, Survival, Pancreatic cancer, Chemistry, Ewha Womans University, Cytotoxicity, Animal, Toxicity, Conference, Cancer, Human, Neoplasm, CMC, Safety, Pharmacy, Research, NOAEL, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disulfiram-like drug, No-observed-adverse-effect level, Yale School of Medicine, GBC, Diagnosis, Food, Patient, Medical imaging, Pharmaceutical industry

This chemotherapy is a patient-centered treatment that focuses on controlling toxicity of anticancer drug.

Key Points: 
  • This chemotherapy is a patient-centered treatment that focuses on controlling toxicity of anticancer drug.
  • Polytaxel is loaded with docetaxel as its active pharmaceutical ingredient, which is known as one of the major chemotherapy drugs.
  • He said, "Based on the very low toxicity of Polytaxel, a completely new standard treatment to enable pain-free anticancer treatment has emerged."
  • For the two-dose group, it will take 8 days to complete administration, and 15 days for the three-dose group.

The Korea Society of Ginseng Announces Red Ginseng Reduces Fatigue and Stress

Retrieved on: 
Tuesday, April 26, 2022
Chronic cough, DNA, Lethargy, Woman, COVID-19, WHO, Fatigue, Ageusia, Genetics, Research, Taste, The Korea Society, Molecular medicine, Effect, Department, Patient, Breathe Me, OC43, Conference, Hematology, Learned helplessness, Professor, BFI, Sejong University, Female, Ewha Womans University, Colorectal cancer, Smell, Coronavirus, Anosmia, John Foster Dulles, Male, Chronic fatigue, Cancer, Animal, Hospital, Pharmaceutical industry, Medicine, Dietary supplement

SEOUL, South Korea, April 26, 2022 /PRNewswire/ -- The Korea Society of Ginseng disclosed the results of a study titled The Effect of Red Ginseng on Improving Fatigue, Lethargy and Stress Resistance at The Korea Society of Ginseng Spring Conference in 2022 held at Sejong University on the 21st. In particular, the timeliness of the results of this study are especially meaningful since an increasing number of people have complained of lingering fatigue and lethargy following recovery from coronavirus infection.

Key Points: 
  • - The Korea Society of Ginseng presented the results of a study on the effect of red ginseng on improving fatigue and lethargy.
  • SEOUL, South Korea, April 26, 2022 /PRNewswire/ --The Korea Society of Ginseng disclosed the results of a study titled The Effect of Red Ginseng on Improving Fatigue, Lethargy and Stress Resistance at The Korea Society of Ginseng Spring Conference in 2022 held at Sejong University on the 21st.
  • - According to Kim Kyung-chul, a family medicine specialist, red ginseng effectively reduces fatigue and stress.
  • The red ginseng group took 1000mg of red ginseng twice a day during the 16 weeks of chemotherapy.

Samyang Biopharm USA Announces Appointment of Eun-Ju Ryu as New President

Retrieved on: 
Tuesday, February 8, 2022
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Infectious Diseases, Clinical Trials, Sookmyung Women's University, MBA, Clinical trial, Growth, Berks County Community Foundation, Ewha Womans University, Eun-ju, Patient, Clinical trial management system, University, Minister of Health and Welfare v Woodcarb, Pfizer, County, Therapy, Business development, Renewable energy, Pharmaceutical industry, New York University, Pharmacy, IND, Neuroscience, Health

Samyang Biopharm USA, Inc. ( https://us.samyangbiopharm.com ) a global biotech subsidiary of the Samyang Holdings Corp. ( https://samyangbiopharm.com/eng ), announced today that Eun-Ju Ryu has been appointed President of Samyang Biopharm USA, end of Jan. 2022.

Key Points: 
  • Samyang Biopharm USA, Inc. ( https://us.samyangbiopharm.com ) a global biotech subsidiary of the Samyang Holdings Corp. ( https://samyangbiopharm.com/eng ), announced today that Eun-Ju Ryu has been appointed President of Samyang Biopharm USA, end of Jan. 2022.
  • This experience will help Samyang Biopharm USA reach the next level of growth and achievement.
  • Ms. Ryu brings over 30 years of experience in the biopharmaceutical industry to her leadership position at Samyang Biopharm USA.
  • I am excited to become President of Samyang Biopharm USA as the company continues to build its pipeline in select oncology indications with the ultimate goal of providing life-changing medicines for patients, said Ms. Eun-Ju Ryu, President of Samyang Biopharm USA.

Financial Industry Veteran Dianne Seo Joins Trusaic as CFO

Retrieved on: 
Tuesday, February 8, 2022
NASDAQ, CFO, Metrobank, Forecasting, IPO, Schiller International University, Ewha Womans University, Commercial bank, HR, SEC, CEO, Workforce, Workplace, Organization, Cathay Bank, Information technology, Seo, MBA, Management, Security (finance)

LOS ANGELES, Feb. 8, 2022 /PRNewswire/ -- Trusaic, a leading software company specializing in advanced pay equity analytics, announces the appointment of financial industry veteran Dianne Seo to Chief Financial Officer (CFO).

Key Points: 
  • LOS ANGELES, Feb. 8, 2022 /PRNewswire/ -- Trusaic, a leading software company specializing in advanced pay equity analytics, announces the appointment of financial industry veteran Dianne Seo to Chief Financial Officer (CFO).
  • Seo will oversee all financial operations for Trusaic and partner with the senior leadership team to drive strategic growth across the company's lines of business.
  • "Dianne is uniquely qualified to establish the financial framework to support Trusaic's growth," says Robert Sheen, CEO of Trusaic.
  • Most recently, Seo served as CFO of Ohana Pacific Bank in Honolulu.

SOM Biotech Announces the In Vitro Confirmation of Three Drug Candidates for COVID-19 in Collaboration with the Ewha Womans University

Retrieved on: 
Tuesday, April 21, 2020
Viruses, Zoonoses, Animal diseases, Respiratory diseases, Health in Saudi Arabia, In Saudi Arabia, SOM Biotech, Middle East respiratory syndrome-related coronavirus, Ewha Womans University, CoV, Severe acute respiratory syndrome

BARCELONA, Spain, April 21, 2020 /PRNewswire/ -- SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19.

Key Points: 
  • BARCELONA, Spain, April 21, 2020 /PRNewswire/ -- SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19.
  • SOM Biotech has applied its artificial intelligence based screening technology (SOMAIPRO) to identify inhibitors of the 3CL proteases of SARS-CoV-2, SARS-CoV and MERS-CoV viruses as potential candidates to treat COVID-19.
  • The discoveries came as a result of the research conducted jointly by SOM Biotech and the Department of Pharmacy and Pharmaceutical Sciences led by Professor Dong-Hae Shin from Ewha Womans University in South Korea.
  • Within the three identified and validated drug candidates, one - Eravacycline - is an already approved drug.

SOM Biotech Announces the In Vitro Confirmation of Three Drug Candidates for COVID-19 in Collaboration with the Ewha Womans University

Retrieved on: 
Tuesday, April 21, 2020
Viruses, Zoonoses, Animal diseases, Respiratory diseases, Health in Saudi Arabia, In Saudi Arabia, SOM Biotech, Middle East respiratory syndrome-related coronavirus, Ewha Womans University, CoV, Severe acute respiratory syndrome

BARCELONA, Spain, April 21, 2020 /PRNewswire/ -- SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19.

Key Points: 
  • BARCELONA, Spain, April 21, 2020 /PRNewswire/ -- SOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19.
  • SOM Biotech has applied its artificial intelligence based screening technology (SOMAIPRO) to identify inhibitors of the 3CL proteases of SARS-CoV-2, SARS-CoV and MERS-CoV viruses as potential candidates to treat COVID-19.
  • The discoveries came as a result of the research conducted jointly by SOM Biotech and the Department of Pharmacy and Pharmaceutical Sciences led by Professor Dong-Hae Shin from Ewha Womans University in South Korea.
  • Within the three identified and validated drug candidates, one - Eravacycline - is an already approved drug.